Amgen (AMGN) Receivables - Net (2009 - 2026)

Amgen (AMGN) has reported Receivables - Net for 18 consecutive years, with $9.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables - Net rose 12.37% year-over-year to $9.1 billion; the TTM figure through Mar 2026 stood at $9.1 billion (up 12.37% YoY), while the FY2025 annual figure was $9.6 billion, up 41.11% from the prior year.
• Receivables - Net came in at $9.1 billion for Q1 2026 at Amgen, down from $9.6 billion in the prior quarter.
• The five-year high for Receivables - Net was $9.6 billion in Q4 2025, with the low at $5.1 billion in Q1 2022.
• Average Receivables - Net over 5 years is $6.9 billion, with a median of $6.8 billion recorded in 2024.
• Across the five-year window, Receivables - Net retreated 6.69% in 2024 and jumped 41.11% in 2025, its largest moves.
• Year by year, Receivables - Net stood at $5.6 billion in 2022, then soared by 30.65% to $7.3 billion in 2023, then dropped by 6.69% to $6.8 billion in 2024, then surged by 41.11% to $9.6 billion in 2025, then decreased by 4.51% to $9.1 billion in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $9.1 billion, $9.6 billion, and $8.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.